Ciezki JP, Weller M, Reddy CA, Kittel J, Singh H, Tendulkar R, Stephans KL, Ulchaker J, Angermeier K, Stephenson A et al (2017) A comparison between low-dose-rate brachytherapy with or without androgen deprivation, external beam radiation therapy with or without androgen deprivation, and radical prostatectomy with or without adjuvant or salvage radiation therapy for high-risk prostate cancer. Int J Radiat Oncol Biol Phys 97:962–975. https://doi.org/10.1016/j.ijrobp.2016.12.014

Article  PubMed  Google Scholar 

Campbell JM, Raymond E, O’Callaghan ME, Vincent AD, Beckmann KR, Roder D, Evans S, McNeil J, Millar J, Zalcberg J et al (2017) Optimum tools for predicting clinical outcomes in prostate cancer patients undergoing radical prostatectomy: a systematic review of prognostic accuracy and validity. Clin Genitourin Cancer 15:e827–e834. https://doi.org/10.1016/j.clgc.2017.06.001

Article  PubMed  Google Scholar 

Garg H, Dursun F, Alsayegh F, Wang H, Wu S, Liss MA, Kaushik D, Svatek RS, Mansour AM (2023) Revisiting current National Comprehensive Cancer Network (NCCN) high-risk prostate cancer stratification: a National Cancer Database analysis. Prostate Cancer Prostatic Dis 14:10. https://doi.org/10.1038/s41391-022-00621-7

Article  CAS  Google Scholar 

Wilkins LJ, Tosoian JJ, Reichard CA, Sundi D, Ranasinghe W, Alam R, Schwen Z, Reddy C, Allaf M, Davis JW et al (2021) Oncologic outcomes among Black and White men with grade group 4 or 5 (Gleason score 8–10) prostate cancer treated primarily by radical prostatectomy. Cancer 127:1425–1431. https://doi.org/10.1002/cncr.33419

Article  PubMed  Google Scholar 

Panunzio A, Sorce G, Hoeh B, Hohenhorst L, Tappero S, Nimer N, Rajwa P, Tian Z, Terrone C, Chun FKH et al (2023) Effect of positive surgical margins at radical prostatectomy on cancer-specific mortality in high/very high-risk prostate cancer patients with Gleason Grade Group 4–5. Prostate 83:268–276. https://doi.org/10.1002/pros.24458

Article  CAS  PubMed  Google Scholar 

Kamitani R, Matsumoto K, Kosaka T, Takeda T, Hashiguchi A, Tanaka N, Morita S, Mizuno R, Shinojima T, Asanuma H, Oya M (2021) Evaluation of Gleason Grade Group 5 in a contemporary prostate cancer grading system and literature review. Clin Genitourin Cancer 19:69-75.e5e65. https://doi.org/10.1016/j.clgc.2020.08.001

Article  PubMed  Google Scholar 

Ellis CL, Partin AW, Han M, Epstein JI (2013) Adenocarcinoma of the prostate with Gleason score 9–10 on core biopsy: correlation with findings at radical prostatectomy and prognosis. J Urol 190:2068–2073. https://doi.org/10.1016/j.juro.2013.05.056

Article  PubMed  Google Scholar 

Wenzel M, Würnschimmel C, Chierigo F, Mori K, Tian Z, Terrone C, Shariat SF, Saad F, Tilki D, Graefen M et al (2022) Pattern of biopsy Gleason Grade Group 5 (4 + 5 vs 5 + 4 vs 5 + 5) predicts survival after radical prostatectomy or external beam radiation therapy. Eur Urol Focus 8:710–717. https://doi.org/10.1016/j.euf.2021.04.011

Article  PubMed  Google Scholar 

Lattouf JB, Saad F (2002) Gleason score on biopsy: is it reliable for predicting the final grade on pathology? BJU Int 90:694–698. https://doi.org/10.1046/j.1464-410x.2002.02990.x. (discussion 698–699)

Article  PubMed  Google Scholar 

Kato D, Ebara S, Tatenuma T, Sasaki T, Ikehata Y, Nakayama A, Toide M, Yoneda T, Sakaguchi K, Teishima J et al (2022) Short-term oncological and surgical outcomes of robot-assisted radical prostatectomy: a retrospective multicenter cohort study in Japan (the MSUG94 group). Asian J Endosc Surg 15:745–752. https://doi.org/10.1111/ases.13074

Article  PubMed  Google Scholar 

Sasaki T, Ebara S, Tatenuma T, Ikehata Y, Nakayama A, Kawase M, Toide M, Yoneda T, Sakaguchi K, Teishima J et al (2023) Prognostic differences among the positive surgical margin locations following robot-assisted radical prostatectomy in a large Japanese cohort (the MSUG94 group). Jpn J Clin Oncol 53:443–451. https://doi.org/10.1093/jjco/hyad004

Article  PubMed  Google Scholar 

Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, Mason M, Matveev V, Wiegel T, Zattoni F et al (2014) EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol 65:467–479. https://doi.org/10.1016/j.eururo.2013.11.002

Article  CAS  PubMed  Google Scholar 

Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA, Grading Committee (2016) The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol 40:244–252. https://doi.org/10.1097/PAS.0000000000000530

Moschini M, Sharma V, Soligo M, Psutka S, Rangel L, Boorjian SA, Frank I, Gettman MT, Thompson RH, Tollefson MK, Karnes RJ (2018) Heterogeneity of risk within Gleason 4 + 4, 4 + 5 and 5 + 4 prostate cancer. Scand J Urol 52:340–348. https://doi.org/10.1080/21681805.2018.1534886

Article  PubMed  Google Scholar 

Tilki D, Würnschimmel C, Preisser F, Graefen M, Huland H, Mandel P, Tennstedt P (2020) The significance of primary biopsy Gleason 5 in patients with grade Group 5 prostate cancer. Eur Urol Focus 6:255–258. https://doi.org/10.1016/j.euf.2020.01.008

Article  PubMed  Google Scholar 

Kishan AU, Shaikh T, Wang PC, Reiter RE, Said J, Raghavan G, Nickols NG, Aronson WJ, Sadeghi A, Kamrava M et al (2017) Clinical outcomes for patients with Gleason score 9–10 prostate adenocarcinoma treated with radiotherapy or radical prostatectomy: a multi-institutional comparative analysis. Eur Urol 71:766–773. https://doi.org/10.1016/j.eururo.2016.06.046

Article  PubMed  Google Scholar 

Kishan AU, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Sandler KA, Stock RG et al (2018) Radical prostatectomy, external beam radiotherapy, or external beam radiotherapy with brachytherapy boost and disease progression and mortality in patients with Gleason score 9–10 prostate cancer. JAMA 319:896–905. https://doi.org/10.1001/jama.2018.0587

Article  PubMed  PubMed Central  Google Scholar 

Muralidhar V, Mahal BA, Butler S, Lamba N, Yang DD, Leeman J, D’Amico AV, Nguyen PL, Trinh QD, Orio PF 3rd, King MT (2019) Combined external beam radiation therapy and brachytherapy versus radical prostatectomy with adjuvant radiation therapy for Gleason 9–10 prostate cancer. J Urol 202:973–978. https://doi.org/10.1097/JU.0000000000000352

Article  PubMed  Google Scholar 

Knipper S, Palumbo C, Pecoraro A, Rosiello G, Tian Z, Briganti A, Zorn KC, Saad F, Tilki D, Graefen M, Karakiewicz PI (2020) Survival outcomes of radical prostatectomy vs. external beam radiation therapy in prostate cancer patients with Gleason Score 9–10 at biopsy: a population-based analysis. Urol Oncol 38:79.e9-79.e14. https://doi.org/10.1016/j.urolonc.2019.09.015

Article  PubMed  Google Scholar 

Chao HH, Soni PD, Dahman B, Stilianoudakis SC, Ford H, Singh R, Freedland SJ, Moghanaki D, Vapiwala N, Chang MG (2022) Outcomes following radical prostatectomy or external beam radiation for veterans with Gleason 9 and 10 prostate cancer. Cancer Med 11:2886–2895. https://doi.org/10.1002/cam4.4656

Article  PubMed  PubMed Central  Google Scholar 

Flood TA, Schieda N, Sim J, Breau RH, Morash C, Belanger EC, Robertson SJ (2018) Evaluation of tumor morphologies and association with biochemical recurrence after radical prostatectomy in Grade Group 5 prostate cancer. Virchows Arch 472:205–212. https://doi.org/10.1007/s00428-017-2241-9

Article  PubMed  Google Scholar 

Velho PI, Lim D, Wang H, Park JC, Kaur HB, Almutairi F, Carducci MA, Denmeade SR, Markowski MC, Isaacs WB et al (2019) Molecular characterization and clinical outcomes of primary Gleason Pattern 5 prostate cancer after radical prostatectomy. JCO Precis Oncol. https://doi.org/10.1200/PO.19.00081

Article  PubMed  Google Scholar 

Antunes AA, Srougi M, Dall’Oglio MF, Crippa A, Campagnari JC, Leite KR (2005) The percentage of positive biopsy cores as a predictor of disease recurrence in patients with prostate cancer treated with radical prostatectomy. BJU Int 96:1258–1263. https://doi.org/10.1111/j.1464-410X.2005.05823.x

Article  PubMed  Google Scholar 

Yamashita S, Kohjimoto Y, Sato H, Kikkawa K, Sonomura T, Hara I (2022) PI-RADS v2 findings of MRI and positive biopsy core percentage would predict pathological extraprostatic extension in patients who underwent robot assisted radical prostatectomy: a retrospective study. Urol J 19:438–444. https://doi.org/10.22037/uj.v19i.6923

Article  PubMed  Google Scholar 

Gandaglia G, Ploussard G, Valerio M, Mattei A, Fiori C, Fossati N, Stabile A, Beauval JB, Malavaud B, Roumiguié M et al (2019) A novel nomogram to identify candidates for extended pelvic lymph node dissection among patients with clinically localized prostate cancer diagnosed with magnetic resonance imaging-targeted and systematic biopsies. Eur Urol 75:506–514. https://doi.org/10.1016/j.eururo.2018.10.012

Article  PubMed  Google Scholar 

Van den Broeck T, van den Bergh RCN, Arfi N, Gross T, Moris L, Briers E, Cumberbatch M, De Santis M, Tilki D, Fanti S et al (2019) Prognostic value of biochemical recurrence following treatment with curative intent for prostate cancer: a systematic review. Eur Urol 75:967–987. https://doi.org/10.1016/j.eururo.2018.10.011

Article  PubMed  Google Scholar